SEC Comment Letter for MYRIAD GENETICS INC (MYGN) (CIK 0000899923) (MYGN) — Mar 30, 2012
MYRIAD GENETICS INC (MYGN) (CIK 0000899923)
Date: March 30, 2012 · CIK: 0000899923 · Accession: 0000000000-12-016346
AI Filing Summary & Sentiment
File numbers found in text: 000-26642
Show Raw Text
March 30, 2012 Via E-mail Mr. James S. Evans Chief Financial Officer Myriad Genetics, Inc. 320 Wakara Way Salt Lake City, UT 84108 Re: Myriad Genetics, Inc. Form 10-K for the Fiscal Year Ended June 30, 2011 Filed August 15, 2011 File No. 000-26642 Dear Mr. Evans: We have completed our review of your f iling. We remind you that our comments or changes to disclosure in res ponse to our comments do not for eclose the Commission from taking any action with respect to the company or the filings and the company may not assert staff comments as a defense in any proceeding ini tiated by the Commission or any person under the federal securities laws of the United States. We urge all pers ons who are responsible for the accuracy and adequacy of the disclosure in the fi lings to be certain that the filings include the information the Securities Exchange Act of 1934 and all applicable rules require. Sincerely, /s/ Joel Parker Joel Parker Accounting Branch Chief